Bird & Bird advises CDP Venture Capital on Series A investment into Naturbeads

International law firm Bird & Bird has advised CDP Venture Capital, the largest venture capital manager in Italy, in connection with its recent investment in UK start-up Naturbeads, as part of a £7.8 million Series A round.

Naturbeads, a Bath University-founded startup, produces biodegradable cellulose microspheres as an alternative to microplastics in various products including cosmetics, detergents, and paints. Their innovative approach aims to reduce environmental pollution by replacing harmful microplastics with sustainable, natural materials.

The Series A funding round will allow Naturbeads to further develop its pioneering technology that aims to address worldwide microplastic pollution.

CDP Venture Capital, headquartered in Rome, Italy, is a venture capital firm that invests in seed-stage, early-stage, growth-stage, and later-stage companies across various sectors. These include consumer products, energy, healthcare, and technology.

The Bird & Bird team consisted of partners Adam Meisels (Corporate, London) and Calogero Porrello (Corporate, Milan), and associates Benjamin Simon (Corporate, London), Sara Calamitosi (Corporate, Milan) and Caitlin Cowan (Corporate, London).

Adam Meisels, lead partner on the transaction, commented: “We are pleased to have assisted CDP with this investment. Recent studies on the dangers of microplastics to both wildlife and the human population underscore the importance of this transaction. Additionally, this deal highlights Bird & Bird’s sector-leading expertise in the sustainability sector.”

News & Deals

More News & Deals
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More

Related capabilities